Komori
GNI Group (2160) · InitiativeFirst stated

Additional Acquisition of Cullgen Series B Preferred Shares

First written in FY2024-Q1. . Latest entry: FY2024-Q1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Expansion of the Drug Discovery Business Stake Through Additional Investment in CullgenA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2024-Q1First statedAnnual report

    「2024年１月10日付けで、当社はCVI Investments Inc.の保有するCullgenのシリーズＢ優先株式4,819,278株について、総額3,269,100千円にて取得いたしました。その結果、当社グループのCullgen及びCullgen SHの持分は、33.18％から39.60％へ増加いたしました。」

    CullgenのシリーズB優先株式を取得し、Cullgen及びCullgen SHに対するグループ持分を33.18％から39.60％へ引き上げた。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for GNI Group yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.